These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11487206)

  • 1. Proton magnetic resonance spectroscopy (1H-MRS) of motor cortex and basal ganglia in de novo Parkinson's disease patients.
    Lucetti C; Del Dotto P; Gambaccini G; Bernardini S; Bianchi MC; Tosetti M; Bonuccelli U
    Neurol Sci; 2001 Feb; 22(1):69-70. PubMed ID: 11487206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic changes in de novo Parkinson's disease after dopaminergic therapy: A proton magnetic resonance spectroscopy study.
    Ciurleo R; Bonanno L; Di Lorenzo G; Bramanti P; Marino S
    Neurosci Lett; 2015 Jul; 599():55-60. PubMed ID: 26007705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influences of dopaminergic treatment on motor cortex in Parkinson disease: a MRI/MRS study.
    Lucetti C; Del Dotto P; Gambaccini G; Ceravolo R; Logi C; Berti C; Rossi G; Bianchi MC; Tosetti M; Murri L; Bonuccelli U
    Mov Disord; 2007 Nov; 22(15):2170-5. PubMed ID: 17722082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting.
    Almuqbel M; Melzer TR; Myall DJ; MacAskill MR; Pitcher TL; Livingston L; Wood KL; Keenan RJ; Dalrymple-Alford JC; Anderson TJ
    Parkinsonism Relat Disord; 2016 Jan; 22():54-61. PubMed ID: 26627939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and application of neurochemical profile by multiple regional
    Guan J; Rong Y; Wen Y; Wu H; Qin H; Zhang Q; Chen W
    Brain Behav; 2017 Sep; 7(9):e00792. PubMed ID: 28948086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Magnetic resonance spectroscopy in Parkinson's disease and multiple system atrophy].
    Aotsuka A; Shinotoh H; Hattori T
    Nihon Rinsho; 1997 Jan; 55(1):249-54. PubMed ID: 9014459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton MR spectroscopy in idiopathic spasmodic torticollis.
    Federico F; Lucivero V; Simone IL; Defazio G; De Salvia R; Mezzapesa DM; Petruzzellis M; Tortorella C; Livrea P
    Neuroradiology; 2001 Jul; 43(7):532-6. PubMed ID: 11512580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unchanged basal ganglia N-acetylaspartate and glutamate in idiopathic Parkinson's disease measured by proton magnetic resonance spectroscopy.
    Clarke CE; Lowry M; Horsman A
    Mov Disord; 1997 May; 12(3):297-301. PubMed ID: 9159722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.
    Chang L; Lee PL; Yiannoutsos CT; Ernst T; Marra CM; Richards T; Kolson D; Schifitto G; Jarvik JG; Miller EN; Lenkinski R; Gonzalez G; Navia BA;
    Neuroimage; 2004 Dec; 23(4):1336-47. PubMed ID: 15589098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal ganglia metabolite concentrations in idiopathic Parkinson's disease and multiple system atrophy measured by proton magnetic resonance spectroscopy.
    Clarke CE; Lowry M
    Eur J Neurol; 2000 Nov; 7(6):661-5. PubMed ID: 11136352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in putamen N-acetylaspartate and choline ratios in untreated and levodopa-treated Parkinson's disease: a proton magnetic resonance spectroscopy study.
    Ellis CM; Lemmens G; Williams SC; Simmons A; Dawson J; Leigh PN; Chaudhuri KR
    Neurology; 1997 Aug; 49(2):438-44. PubMed ID: 9270574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolite profile in the basal ganglia of children with cerebral palsy: a proton magnetic resonance spectroscopy study.
    Kulak W; Sobaniec W; Smigielska-Kuzia J; Kubas B; Walecki J
    Dev Med Child Neurol; 2006 Apr; 48(4):285-9. PubMed ID: 16542516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marked N-acetylaspartate and choline metabolite changes in Parkinson's disease patients with mild cognitive impairment.
    Nie K; Zhang Y; Huang B; Wang L; Zhao J; Huang Z; Gan R; Wang L
    Parkinsonism Relat Disord; 2013 Mar; 19(3):329-34. PubMed ID: 23238068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The usage of proton magnetic resonance spectroscopy in Parkinson's disease.
    Metarugcheep P; Hanchaiphiboolkul S; Viriyavejakul A; Chanyawattiwongs S
    J Med Assoc Thai; 2012 Jul; 95(7):949-52. PubMed ID: 22919991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton magnetic resonance spectroscopy and cognition in patients with spastin mutations.
    Erichsen AK; Server A; Landrø NI; Sandvik L; Tallaksen CM
    J Neurol Sci; 2009 Feb; 277(1-2):124-9. PubMed ID: 19084842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis.
    Pohl C; Block W; Karitzky J; Träber F; Schmidt S; Grothe C; Lamerichs R; Schild H; Klockgether T
    Arch Neurol; 2001 May; 58(5):729-35. PubMed ID: 11346367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy.
    Federico F; Simone IL; Lucivero V; De Mari M; Giannini P; Iliceto G; Mezzapesa DM; Lamberti P
    J Neurol Neurosurg Psychiatry; 1997 Mar; 62(3):239-42. PubMed ID: 9069478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in temporal N-acetylaspartate and creatine (or choline) ratio in temporal lobe epilepsy: does this 1H-magnetic resonance spectroscopy finding mean poor seizure control?
    Mendes-Ribeiro JA; Soares R; Simões-Ribeiro F; Guimarães ML
    J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):518-22. PubMed ID: 9771777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton MR spectroscopic imaging of the striatum in Parkinson's disease.
    Cruz CJ; Aminoff MJ; Meyerhoff DJ; Graham SH; Weiner MW
    Magn Reson Imaging; 1997; 15(6):619-24. PubMed ID: 9285801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brainstem 1H-MR spectroscopy in patients with Parkinson's disease with REM sleep behavior disorder and IPD patients without dream enactment behavior.
    Hanoglu L; Ozer F; Meral H; Dincer A
    Clin Neurol Neurosurg; 2006 Feb; 108(2):129-34. PubMed ID: 15936138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.